Uzbekistan plans to increase pharmaceutical production to 8.5 trln soums ($697 mln) in 2026, the Ministry of Justice said, citing a presidential decree.
To reach this target, the country will launch investment projects worth a total of $800 mln. After patents on original medicines expire, the government will provide support to domestic producers.
Producers will be reimbursed for 50% of technology transfer costs up to $50,000, or 50% of research expenses for new drug development up to $100,000.
From January 1, 2027, companies holding a national GMP certificate will be allowed to produce dietary supplements on their own production lines.
From economics and politics to business, technology and culture, Kursiv Uzbekistan brings you key news and in-depth analysis from Uzbekistan and around the world. To stay up to date and get the latest stories in real time, follow our Telegram channel.
